Vol 2022, No 6 (2022)

Table of Contents

Research & Development

Novartis Collaborates with Precision Bio in Gene Editing Pact Abstract pdf html
Lucy Haggerty

Licensing

Biogen Licenses Parkinson’s Drug from Alectos Therapeutics for up to US$722.5 M Abstract pdf html
Ashish Tripathi
MorphoSys Out-licenses Two Oncology Antibodies to HIBio Abstract pdf html
Lucy Haggerty
Immatics and Bristol Myers Squibb Expand Alliance to Develop Cell Therapy Programmes Abstract pdf html
Swati Sharan

Mergers & Acquisitions

GlaxoSmithKline Acquires Affinivax for US$3.3 B Abstract pdf html
Lucy Haggerty
Bristol Myers Squibb Buys Turning Point for US$4.1 B Abstract pdf html
Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.